Pain Responses in Patients on Long-Term Opioid Therapy for Chronic Pain
NCT00656942 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 419
Last updated 2020-07-22
Summary
The MGH Center for Translational Pain Research is seeking patients with chronic pain for a research study. The study is looking at the effect of opioid (narcotic) pain medicines on pain sensation, threshold and tolerance.
Conditions
Interventions
- DEVICE
-
Quantitative Sensory Testing (QST)
QST consists of a series of heat and cold stimulation tests.
Sponsors & Collaborators
-
Massachusetts General Hospital
lead OTHER
Principal Investigators
-
Jianren Mao, MD · Massachusetts General Hospital
Eligibility
- Min Age
- 18 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2006-07-31
- Primary Completion
- 2013-10-31
- Completion
- 2018-12-31
Countries
- United States
Study Locations
More Related Trials
-
Effect of Guanfacine on the Reversal of Opioid-induced Hyperalgesia (OIH)
NCT02192398 ·Status: TERMINATED ·Phase: NA
-
Effect of Ketamine on Opioid-Induced Hyperalgesia
NCT00833755 ·Status: COMPLETED ·Phase: NA
-
Brain Response to Pain Control in People With Chronic Pain
NCT01878019 ·Status: COMPLETED
-
A Brief Intervention for Patients on Opioids for Acute Pain
NCT05658926 ·Status: COMPLETED ·Phase: NA
-
Opioid Titration Order Sheet or Standard Care in Treating Patients With Cancer Pain
NCT00666211 ·Status: COMPLETED ·Phase: PHASE3
-
Using Mobile Devices for Neurofeedback to Reduce Opioid Use in Chronic Pain
NCT04838925 ·Status: UNKNOWN ·Phase: NA
-
Analgesic Tolerance to Repeated Doses of Subcutaneous Morphine
NCT00256347 ·Status: COMPLETED ·Phase: NA
-
Fentanyl Administered Intraorally for Rapid Treatment of Orthopedic Pain
NCT00685295 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Study to Evaluate the Efficacy and Safety of ORAVESCENT Fentanyl Citrate for Management of Breakthrough Pain
NCT00214942 ·Status: COMPLETED ·Phase: PHASE3
-
Study to Evaluate the Efficacy and Safety of ORAVESCENT Fentanyl Citrate for the Management of Breakthrough Pain
NCT00214955 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluation of Medical Cannabis and Prescription Opioid Taper Support for Reduction of Pain and Opioid Dose in Patients With Chronic Non-Cancer Pain
NCT04827992 ·Status: COMPLETED ·Phase: NA
-
Prospective Evaluation of Intrathecal Targeted Drug Delivery for Cancer Associated Pain
NCT05674240 ·Status: COMPLETED
-
Evaluating the Efficacy of Intranasal Oxytocin on Chronic Pain
NCT04903002 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2/PHASE3
-
The Effectiveness and Tolerability of Fentanyl Matrix in Chronic Non-cancer Pain; Assessment of Patient's Pain Treatment Goal Achievement
NCT01688583 ·Status: COMPLETED
-
Study of the Characteristics of Chronic Pain in Patients With Addiction
NCT05976178 ·Status: COMPLETED
-
Human Brain Adaptation to Chronic Pain and Its Effects on Opioid Use
NCT03248765 ·Status: TERMINATED
-
A Depression and Opioid Pragmatic Trial in Pharmacogenetics (Chronic Pain Trial)
NCT05966142 ·Status: COMPLETED ·Phase: NA
-
Can Medical Cannabis Affect Opioid Use?
NCT06206252 ·Status: RECRUITING
-
An Efficacy and Safety Study of Fentanyl in Participants With Chronic Pain
NCT00788372 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety Study of NKTR-181 in Opioid-Naive Subjects With Low Back Pain
NCT02362672 ·Status: COMPLETED ·Phase: PHASE3
-
Prometra's Utilization in Mitigating Pain (PUMP)
NCT00817596 ·Status: COMPLETED ·Phase: NA
-
Pain Control in Hospice Patients With Cancer-Related Pain
NCT00609297 ·Status: COMPLETED
-
A Study to Evaluate the Safety of D-TRANS Fentanyl With Naltrexone in Adult Patients With Chronic Pain and Who Are Opioid Tolerant
NCT00650182 ·Status: COMPLETED ·Phase: PHASE2
-
Cognitive Function and Addiction Under Opioid Tapering
NCT03365817 ·Status: COMPLETED ·Phase: PHASE3
-
Correlation Between the Analgesic Effect of Fentanyl Transdermal Patches and Nutritional Status in Cancer Pain Patients
NCT06369961 ·Status: COMPLETED